These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

143 related items for PubMed ID: 24983292

  • 21. Usefulness of magnetic resonance imaging of the hand versus anticyclic citrullinated peptide antibody testing to confirm the diagnosis of clinically suspected early rheumatoid arthritis in the absence of rheumatoid factor and radiographic erosions.
    Narváez J, Sirvent E, Narváez JA, Bas J, Gómez-Vaquero C, Reina D, Nolla JM, Valverde J.
    Semin Arthritis Rheum; 2008 Oct; 38(2):101-9. PubMed ID: 18221987
    [Abstract] [Full Text] [Related]

  • 22. Easy and accurate diagnosis of rheumatoid arthritis using anti-cyclic citrullinated peptide 2 antibody, swollen joint count, and C-reactive protein/rheumatoid factor.
    Yamane T, Hashiramoto A, Tanaka Y, Tsumiyama K, Miura Y, Shiozawa K, Chihara K, Shiozawa S.
    J Rheumatol; 2008 Mar; 35(3):414-20. PubMed ID: 18203327
    [Abstract] [Full Text] [Related]

  • 23. Prediction of radiological outcome in early rheumatoid arthritis in clinical practice: role of antibodies to citrullinated peptides (anti-CCP).
    Forslind K, Ahlmén M, Eberhardt K, Hafström I, Svensson B, BARFOT Study Group.
    Ann Rheum Dis; 2004 Sep; 63(9):1090-5. PubMed ID: 15308518
    [Abstract] [Full Text] [Related]

  • 24. High anti-cyclic citrullinated peptide levels and an algorithm of four variables predict radiographic progression in patients with rheumatoid arthritis: results from a 10-year longitudinal study.
    Syversen SW, Gaarder PI, Goll GL, Ødegård S, Haavardsholm EA, Mowinckel P, van der Heijde D, Landewé R, Kvien TK.
    Ann Rheum Dis; 2008 Feb; 67(2):212-7. PubMed ID: 17526555
    [Abstract] [Full Text] [Related]

  • 25. Low-field magnetic resonance imaging or combined ultrasonography and anti-cyclic citrullinated peptide antibody improve correct classification of individuals as established rheumatoid arthritis: results of a population-based, cross-sectional study.
    Pedersen JK, Lorenzen T, Ejbjerg B, Szkudlarek M, Voss A, Østergaard M, Svendsen AJ, Andersen LS, Hørslev-Petersen K.
    BMC Musculoskelet Disord; 2014 Aug 07; 15():268. PubMed ID: 25103610
    [Abstract] [Full Text] [Related]

  • 26. Diagnostic performance of anti-cyclic citrullinated peptide and rheumatoid factor in patients with rheumatoid arthritis.
    Chang PY, Yang CT, Cheng CH, Yu KH.
    Int J Rheum Dis; 2016 Sep 07; 19(9):880-6. PubMed ID: 25940989
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Predictors of radiographic progression in the ESPOIR cohort: the season of first symptoms may influence the short-term outcome in early arthritis.
    Mouterde G, Lukas C, Logeart I, Flipo RM, Rincheval N, Daurès JP, Combe B.
    Ann Rheum Dis; 2011 Jul 07; 70(7):1251-6. PubMed ID: 21515603
    [Abstract] [Full Text] [Related]

  • 31. Combination of ultrasound power Doppler-verified synovitis and seropositivity accurately identifies patients with early-stage rheumatoid arthritis.
    Kawashiri SY, Fujikawa K, Nishino A, Takatani A, Shimizu T, Umeda M, Fukui S, Igawa T, Koga T, Iwamoto N, Ichinose K, Tamai M, Nakamura H, Origuchi T, Mizokami A, Maeda T, Kawakami A.
    Int J Rheum Dis; 2019 May 07; 22(5):842-851. PubMed ID: 30883001
    [Abstract] [Full Text] [Related]

  • 32. Prognostic factors in a large cohort of patients with early undifferentiated inflammatory arthritis after application of a structured management protocol.
    Quinn MA, Green MJ, Marzo-Ortega H, Proudman S, Karim Z, Wakefield RJ, Conaghan PG, Emery P.
    Arthritis Rheum; 2003 Nov 07; 48(11):3039-45. PubMed ID: 14613264
    [Abstract] [Full Text] [Related]

  • 33. The likelihood of persistent arthritis increases with the level of anti-citrullinated peptide antibody and immunoglobulin M rheumatoid factor: a longitudinal study of 376 patients with very early undifferentiated arthritis.
    Mjaavatten MD, van der Heijde D, Uhlig T, Haugen AJ, Nygaard H, Sidenvall G, Helgetveit K, Kvien TK.
    Arthritis Res Ther; 2010 Nov 07; 12(3):R76. PubMed ID: 20444271
    [Abstract] [Full Text] [Related]

  • 34. A comparison between IgG- and IgA-class antibodies to cyclic citrullinated peptides and to modified citrullinated vimentin in early rheumatoid arthritis and very early arthritis.
    Svärd A, Kastbom A, Söderlin MK, Reckner-Olsson Å, Skogh T.
    J Rheumatol; 2011 Jul 07; 38(7):1265-72. PubMed ID: 21459947
    [Abstract] [Full Text] [Related]

  • 35. Enriching case selection for imminent RA: the use of anti-CCP antibodies in individuals with new non-specific musculoskeletal symptoms - a cohort study.
    Nam JL, Hunt L, Hensor EM, Emery P.
    Ann Rheum Dis; 2016 Aug 07; 75(8):1452-6. PubMed ID: 26395501
    [Abstract] [Full Text] [Related]

  • 36. EULAR definition of "arthralgia suspicious for progression to rheumatoid arthritis" in a large cohort of patients included in a program for rapid diagnosis: role of auto-antibodies and ultrasound.
    Ruta S, Prado ES, Chichande JT, Ruta A, Salvatori F, Magri S, Salinas RG.
    Clin Rheumatol; 2020 May 07; 39(5):1493-1499. PubMed ID: 31933033
    [Abstract] [Full Text] [Related]

  • 37. Can routine clinical measures predict ultrasound-determined synovitis and remission in rheumatoid arthritis patients?
    Nemoto T, Ogasawara M, Matsuki Y, Murayama G, Yamada Y, Sugisaki N, Ando S, Minowa K, Kon T, Tada K, Matsushita M, Yamaji K, Tamura N, Takasaki Y.
    Clin Exp Rheumatol; 2014 May 07; 32(1):54-60. PubMed ID: 24144300
    [Abstract] [Full Text] [Related]

  • 38. A prediction rule for disease outcome in patients with undifferentiated arthritis using magnetic resonance imaging of the wrists and finger joints and serologic autoantibodies.
    Tamai M, Kawakami A, Uetani M, Takao S, Arima K, Iwamoto N, Fujikawa K, Aramaki T, Kawashiri SY, Ichinose K, Kamachi M, Nakamura H, Origuchi T, Ida H, Aoyagi K, Eguchi K.
    Arthritis Rheum; 2009 Jun 15; 61(6):772-8. PubMed ID: 19479686
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. The performance of anti-cyclic citrullinated peptide antibodies in predicting the severity of radiologic damage in inflammatory polyarthritis: results from the Norfolk Arthritis Register.
    Bukhari M, Thomson W, Naseem H, Bunn D, Silman A, Symmons D, Barton A.
    Arthritis Rheum; 2007 Sep 15; 56(9):2929-35. PubMed ID: 17763407
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.